Healthcare Industry News:  EndoAnchor 

Devices Cardiology Surgery Personnel

 News Release - April 1, 2014

Aptus Endosystems Appoints Dr. Bart E. Muhs as Chief Medical Officer

SUNNYVALE, Calif.--(Healthcare Sales & Marketing Network)--Aptus Endosystems, Inc., a medical device company pioneering solutions to enhance aneurysm repair, today announced that it has appointed Bart Edward Muhs, M.D., Ph.D. to the position of Chief Medical Officer. Dr. Muhs has more than 15 years of experience in the medical field with a focus on vascular and endovascular surgery.

Dr. Muhs serves as an Associate Professor of Vascular Surgery and holds the positions of Co-Director, Endovascular Surgery and Clinical Director, Vascular Surgery at the Yale University School of Medicine. He also practices vascular surgery and endovascular interventions at Yale-New Haven Hospital.

“We’re very pleased to welcome Dr. Muhs to Aptus,” said James Reinstein, President and Chief Executive Officer of Aptus Endosystems. “This is an important step in our organizational growth and reinforces our commitment to patients with difficult-to-treat aortic disease. His clinical experience and perspective will be instrumental in our new product development programs, clinical studies, and market development efforts.”

“There has long been a need for further innovation in the area of aneurysm repair,” said Dr. Muhs. “I look forward to working with Aptus in their continued pursuit to improve long-term outcomes and quality of life for patients undergoing vascular procedures.”

Dr. Muhs completed his medical training at the University of Chicago Pritzker School of Medicine and residency at New York University Medical Center. He completed his vascular surgery fellowship at New York University Medical Center and obtained his Ph.D. at Utrecht University in The Netherlands. Dr. Muhs was a United States Fulbright Scholar at the University of Yaounde I in Cameroon, Africa. Dr. Muhs is frequently invited as teaching faculty to vascular and endovascular symposia around the world and has authored more than 100 published articles in the fields of vascular and endovascular surgery.

About Aptus Endosystems, Inc.

Aptus Endosystems is a privately held, Sunnyvale, California-based medical device company that is pioneering solutions to enhance aneurysm repair. Aptus is focused on improving long-term outcomes and quality of life for patients undergoing EVAR and TEVAR procedures. Aptus has developed a unique helical anchor technology that locks the endograft to the aorta to address long-term durability. Aptus has successfully designed and brought to market two endograft anchoring systems that are currently being used in EVAR and TEVAR procedures in the United States and Europe—the Heli-FX EndoAnchor System and the Heli-FX Thoracic EndoAnchor System. For more information, please visit www.aptusendo.com.


Source: Aptus Endosystems

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.